ADVB
ADVB
NASDAQ · Health Care

Advanced Biomed Inc

$4.21
+0.03 (+0.65%)
Financial Highlights (FY 2025)
Revenue
2.80M
Net Income
212.3K
Gross Margin
67.6%
Profit Margin
7.6%
Rev Growth
+8.0%
D/E Ratio
0.14
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 67.6% 67.6% 67.6%
Operating Margin 7.9% 7.8% 7.0%
Profit Margin 7.6% 5.7% 6.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.80M 2.57M 2.30M
Gross Profit 1.89M 1.74M 1.56M
Operating Income 221.3K 201.2K 160.1K
Net Income 212.3K 146.8K 144.9K
Gross Margin 67.6% 67.6% 67.6%
Operating Margin 7.9% 7.8% 7.0%
Profit Margin 7.6% 5.7% 6.3%
Rev Growth +8.0% +18.1% +10.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 486.0K 572.8K 491.9K
Total Equity 3.60M 3.73M 3.52M
D/E Ratio 0.14 0.15 0.14
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 292.7K 271.8K 288.2K
Free Cash Flow 107.9K 122.1K 96.0K